Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 996

Similar articles for PubMed (Select 15324521)

1.

Pharmacodynamic interaction between ezetimibe and rosuvastatin.

Kosoglou T, Statkevich P, Yang B, Suresh R, Zhu Y, Boutros T, Maxwell SE, Tiessen R, Cutler DL.

Curr Med Res Opin. 2004 Aug;20(8):1185-95.

PMID:
15324521
2.

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.

Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.

Curr Med Res Opin. 2006 Oct;22(10):2041-53.

PMID:
17022864
3.

Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe.

Kosoglou T, Statkevich P, Fruchart JC, Pember LJ, Reyderman L, Cutler DL, Guillaume M, Maxwell SE, Veltri EP.

Curr Med Res Opin. 2004 Aug;20(8):1197-207.

PMID:
15324522
4.

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin.

Kosoglou T, Statkevich P, Meyer I, Cutler DL, Musiol B, Yang B, Zhu Y, Maxwell SE, Veltri EP.

Curr Med Res Opin. 2004 Jun;20(6):955-65.

PMID:
15200755
5.

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.

Reyderman L, Kosoglou T, Cutler DL, Maxwell S, Statkevich P.

Curr Med Res Opin. 2005 Aug;21(8):1171-9.

PMID:
16083526
6.
7.
8.

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.

Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.

Curr Med Res Opin. 2004 Sep;20(9):1437-45.

PMID:
15383192
9.

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.

Farnier M, Averna M, Missault L, Vaverkova H, Viigimaa M, Massaad R, Vandormael K, Johnson-Levonas AO, Brudi P.

Int J Clin Pract. 2009 Apr;63(4):547-59. doi: 10.1111/j.1742-1241.2009.02022.x. Epub 2009 Feb 16.

PMID:
19222610
10.
11.

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.

Davidson MH, McGarry T, Bettis R, Melani L, Lipka LJ, LeBeaut AP, Suresh R, Sun S, Veltri EP.

J Am Coll Cardiol. 2002 Dec 18;40(12):2125-34.

12.

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group.

Am Heart J. 2004 Sep;148(3):447-55.

PMID:
15389231
13.

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.

Kerzner B, Corbelli J, Sharp S, Lipka LJ, Melani L, LeBeaut A, Suresh R, Mukhopadhyay P, Veltri EP; Ezetimibe Study Group.

Am J Cardiol. 2003 Feb 15;91(4):418-24.

PMID:
12586255
14.

Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).

Bays HE, Davidson MH, Massaad R, Flaim D, Lowe RS, Tershakovec AM, Jones-Burton C.

Am J Cardiol. 2011 Aug 15;108(4):523-30. doi: 10.1016/j.amjcard.2011.03.079. Epub 2011 May 17.

PMID:
21596364
15.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
16.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
17.

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E; EXPLORER Study Investigators.

Am J Cardiol. 2007 Mar 1;99(5):673-80. Epub 2007 Jan 4.

PMID:
17317370
18.

The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.

Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M; DISCOVERY PENTA investigators.

Curr Med Res Opin. 2005 Aug;21(8):1307-15.

PMID:
16083541
20.

Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemia.

Lipka L, Sager P, Strony J, Yang B, Suresh R, Veltri E; Ezetimibe Study Group.

Drugs Aging. 2004;21(15):1025-32.

PMID:
15631531
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk